SCHEMBL3629797

SCHEMBL3629797

COc1cc(C)c(-c2cccc3c2CCC3=O)c(C)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
BRD4 O60885 2/20 0.41
GAA P10253 2/20 0.41
GLA P06280 1/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
S100A4 P26447 1/20 0.39
TYMS P04818 1/20 0.39
PDE4D Q08499 1/20 0.39
MAOA P21397 1/20 0.38
HTT P42858 1/20 0.38
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
S1PR1 P21453 1/20 0.36
BRAF P15056 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3624614 0.83 TYMS (0.47) KDM4EALDH1A1HPGDBRD4GAA
SCHEMBL15287086 0.83 ALDH1A1 (0.42) KDM4EALDH1A1HPGDBRD4GAA
SCHEMBL16532787 0.82 ALDH1A1 (0.38) KDM4EALDH1A1HPGDBRD4GAA
SCHEMBL17917426 0.78 ALDH1A1 (0.38) ALDH1A1HPGDBRD4GAAKMT2A
SCHEMBL3631135 0.78 ALDH1A1 (0.43) ALDH1A1BRD4GAAKMT2AMEN1
SCHEMBL16193429 0.78 HTR1A (0.50) KDM4EALDH1A1HPGDBRD4GAA
SCHEMBL16532792 0.77 ALDH1A1 (0.34) KDM4EALDH1A1HPGDGAATYMS
SCHEMBL15286902 0.76 FFAR1 (0.46)
SCHEMBL17917429 0.76 FFAR1 (0.41) ALDH1A1GAATYMSPDE4DS1PR1
SCHEMBL4065877 0.76 ALDH1A1 (0.43) KDM4EALDH1A1HPGDGAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7786165-B2 Aminophenylpropanoic acid derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-31 US disclosed
US-7786165-B2 Aminophenylpropanoic acid derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-31 US disclosed
US-7786165-B2 Aminophenylpropanoic acid derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-31 US disclosed
US-20080269220-A1 Aminophenylpropanoic Acid Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 US disclosed
US-20080269220-A1 Aminophenylpropanoic Acid Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 US disclosed
US-20080269220-A1 Aminophenylpropanoic Acid Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 US disclosed
EP-1726580-A1 AMINOPHENYLPROPANOIC ACID DERIVATIVE Takeda Pharmaceutical Company Limited (JP) 2006-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269220-A1 Aminophenylpropanoic Acid Derivative GPR119, GPR55, GPR65 KDM4E 1965/4885ALDH1A1 495/4885HPGD 2123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.